# Rituximab

A type of targeted therapy called a monoclonal antibody.

## Prevalence log

By examining the prevalence of codes (number of patients with the code in their record) broken down by clinical system, we can attempt to validate the clinical code sets and the reporting of the conditions. The low prevalence shows that this drug is not routinely recorded in primary care.

| Date       | Practice system | Population | Patients from ID | Patient from code |
| ---------- | --------------- | ---------- | ---------------: | ----------------: |
| 2023-01-25 | EMIS            | 2440185    |    437 (0.0179%) |     437 (0.0179%) |
| 2023-01-25 | TPP             | 198742     |     7 (0.00352%) |      7 (0.00352%) |
| 2023-01-25 | Vision          | 327926     |    29 (0.00884%) |     29 (0.00884%) |
